{"title":"Index","authors":"","doi":"10.1002/9781119238614.index","DOIUrl":"https://doi.org/10.1002/9781119238614.index","url":null,"abstract":"","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132669424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Multiplicity","authors":"","doi":"10.1002/9781119238614.ch10","DOIUrl":"https://doi.org/10.1002/9781119238614.ch10","url":null,"abstract":"","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116681079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Meta‐Analysis","authors":"Jia-Lin Xia, Guang-Lei Li, Hong-En Liu, Feng-Fei Xia, Xin Gu","doi":"10.1002/9781119238614.ch16","DOIUrl":"https://doi.org/10.1002/9781119238614.ch16","url":null,"abstract":"Background: Both coil embolization (CE) and flow-diverting device (FDD) placement are widely used for treatment of intracranial aneurysms (IAs). The aim of this meta-analysis is to compare the relative clinical safety and efficacy of FDD and CE for the treatment of unruptured IAs. Methods: The PubMed, Embase, and Cochrane Library databases were searched for relevant studies from the date of inception through April 2020. The primary endpoint for this meta-analysis was the 6-month rate of complete occlusion, while secondary endpoints included rates of retreatment, complications, and parental arterial patency. Results:Thismeta-analysis includes 8 studies, which included 839 total patients that underwent FDD and 2734 that underwent CE. FDD group exhibited a significantly higher pooled 6-month complete occlusion rate (P= .02). The subgroup analysis demonstrated that FDD treatment was associated with significantly higher pooled 6-month complete occlusion rates in patients with large or giant IAs (P< .00001), whereas no differences in 6-month complete occlusion rates were observed between the FDD and CE groups of patients with non-large/giant IAs (P= .83). The pooled retreatment (P= .16) and complication (P= .15) rates were comparable between 2 groups. The CE group exhibited significantly higher pooled parent artery patency rate (P= .01). The funnel plots did not reveal any evidence of publication bias. Conclusions: FDDs can be used to effectively and safely treat large and giant IAs, achieving higher rates of complete occlusion than CE treatment. For non-large/giant IAs, we observed comparable efficacy between FDD and CE treatments. Abbreviations: CE = coil embolization, CI = confidence intervals, FDD = flow-diverting device, HR = hazard ratios, IA = intracranial aneurysm, OR = odds ratio.","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"55 20","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"113937170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"n\u0000 ‐of‐1 Trials","authors":"","doi":"10.1002/9781119238614.ch18","DOIUrl":"https://doi.org/10.1002/9781119238614.ch18","url":null,"abstract":"","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116127159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}